Related references
Note: Only part of the references are listed.The renin-angiotensin-aldosterone system and its suppression
Marisa K. Ames et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease
Juliana Isa Beraldo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways
Quanbin Dong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure
Min Lu et al.
IUBMB LIFE (2019)
Tissue, urine and blood metabolite signatures of chronic kidney disease in the 5/6 nephrectomy rat model
Munsoor A. Hanifa et al.
METABOLOMICS (2019)
Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Crosstalk between FGF23-and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy
Ketaki N. Mhatre et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Cardiorenal Syndrome Revisited
Faiez Zannad et al.
CIRCULATION (2018)
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
Min Pi et al.
SCIENTIFIC REPORTS (2018)
FGF23 and Left Ventricular Hypertrophy in Children with CKD
Mark M. Mitsnefes et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Aldosterone Target NGAL (Neutrophil Gelatinase-Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB Pathway
Ernesto Martinez-Martinez et al.
HYPERTENSION (2017)
FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction
Edward R. Smith et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
The transcriptional regulation of the human angiotensinogen gene after high-fat diet is haplotype-dependent: Novel insights into the gene-regulatory networks and implications for human hypertension
Anita Rana et al.
PLOS ONE (2017)
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts
Edward R. Smith et al.
SCIENTIFIC REPORTS (2017)
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Greg H. Tesch et al.
FRONTIERS IN PHARMACOLOGY (2017)
Biomarkers in patients with myocardial fibrosis
Zhe An et al.
OPEN LIFE SCIENCES (2017)
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
Alexander Grabner et al.
SCIENTIFIC REPORTS (2017)
Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
Svetlana Slavic et al.
SCIENTIFIC REPORTS (2017)
ImageJ2: ImageJ for the next generation of scientific image data
Curtis T. Rueden et al.
BMC BIOINFORMATICS (2017)
Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
Maren Leifheit-Nestler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Up-regulation of FGF23 release by aldosterone
Bingbing Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2016)
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
Huixin Hao et al.
ONCOTARGET (2016)
Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease
Midori Hasegawa et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis
Nathan R. Hill et al.
PLOS ONE (2016)
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Alexander Grabner et al.
CELL METABOLISM (2015)
Aldosterone and Left Ventricular Remodeling
C. Catena et al.
HORMONE AND METABOLIC RESEARCH (2015)
Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease
Yalcin Solak et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2015)
Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
Olena Andrukhova et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
Manfred Richter et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Cause of Death in Patients with Reduced Kidney Function
Stephanie Thompson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
Risto Kerkela et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
Peter Wohlfahrt et al.
JACC-HEART FAILURE (2015)
Paricalcitol Downregulates Myocardial ReninAngiotensin and Fibroblast Growth Factor Expression and Attenuates Cardiac Hypertrophy in Uremic Rats
Michael Freundlich et al.
AMERICAN JOURNAL OF HYPERTENSION (2014)
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
Jacob A. Udell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Heart Failure in Patients with Chronic Kidney Disease: A Systematic Integrative Review
Liviu Segall et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease
L. Darryl Quarles
EXPERIMENTAL CELL RESEARCH (2012)
Neutrophil Gelatinase-Associated Lipocalin Is a Novel Mineralocorticoid Target in the Cardiovascular System
Celine Latouche et al.
HYPERTENSION (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
A Comparative Transcriptome Analysis Identifying FGF23 Regulated Genes in the Kidney of a Mouse CKD Model
Bing Dai et al.
PLOS ONE (2012)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Myocardial fibrosis in response to Angiotensin II is preceded by the recruitment of mesenchymal progenitor cells
Mryanda J. Sopel et al.
LABORATORY INVESTIGATION (2011)
Local angiotensin II aggravates cardiac remodeling in hypertension
Jiang Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Regulation of (Pro) Renin Receptor Expression by Glucose-Induced Mitogen-Activated Protein Kinase, Nuclear Factor-κB, and Activator Protein-1 Signaling Pathways
Jiqian Huang et al.
ENDOCRINOLOGY (2010)
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutierrez et al.
CIRCULATION (2009)
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Richard J. Glassock et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Synergistic co-operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin II-induced angiotensinogen gene activation in vascular smooth muscle cells
Mei Han et al.
FEBS JOURNAL (2009)
Sympathetic Activation in Chronic Renal Failure
Markus P. Schlaich et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter
Weihua Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice
Shuntaro Kagiyama et al.
HYPERTENSION RESEARCH (2007)
TGFβ, cardiac fibroblasts, and the fibrotic response
Andrew Leask
CARDIOVASCULAR RESEARCH (2007)
Neuronal angiotensin II type 1 receptor upregulation in heart failure - Activation of activator protein 1 and jun N-terminal kinase
Dongmei Liu et al.
CIRCULATION RESEARCH (2006)
Physiology of local renin-angiotensin systems
Martin Paul et al.
PHYSIOLOGICAL REVIEWS (2006)
Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides
T Tokudome et al.
CIRCULATION (2005)
Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3
D Haffner et al.
JOURNAL OF HYPERTENSION (2005)
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol
ER Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems
W Xiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis
ML Graciano et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Model of robust induction of glomerulosclerosis in mice: Importance of genetic background
LJ Ma et al.
KIDNEY INTERNATIONAL (2003)
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis
D Del Prete et al.
KIDNEY INTERNATIONAL (2003)
Natriuretic peptides: markers or modulators of cardiac hypertrophy?
DG Gardner
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Phorbol ester induction of angiotension-converting enzyme transcription is mediated Egr-1 and AP-1 in human endothelial cells via ERK1/2 pathway
M Eyries et al.
CIRCULATION RESEARCH (2002)
Induction of cardiac fibrosis by aldosterone
P Lijnen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)